Mounjaro (tirzepatide) and Wegovy (semaglutide) are weight-loss medicines that make people feel fuller for longer and therefore less hungry.

Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...

Weight loss injections may have an anti-cancer effect ‘beyond weight loss’ - Weight loss jabs, also known as GLP-1 receptor ...

As the definitive trial comparing Wegovy to Mounjaro is released, experts stress the need for patients to be given the very ...